QPBE
IBB icon

Quintet Private Bank (Europe)’s iShares Biotechnology ETF IBB Stock Holding History

Quintet Private Bank (Europe)’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$105K Sell
500
-100
-17% -$20.1K ﹤0.01% 129
2026
Q2 		$114K Buy
600
+350
+140% +$60.2K 0.01% 115
2026
Q1 		$42.2K Hold
250
– – ﹤0.01% 144
2025
Q4 		$42.2K Sell
250
-250
-50% -$40.6K ﹤0.01% 146
2025
Q3 		$72.2K Sell
500
-1,550
-76% -$212K ﹤0.01% 137
2025
Q2 		$259K Sell
2,050
-6,616
-76% -$812K 0.02% 103
2025
Q1 		$1.11M Sell
8,666
-1,270
-13% -$172K 0.07% 76
2024
Q4 		$1.31M Sell
9,936
-4,816
-33% -$677K 0.07% 74
2024
Q3 		$2.15M Buy
14,752
+2,533
+21% +$367K 0.12% 62
2024
Q2 		$1.93M Buy
12,219
+5,961
+95% +$796K 0.11% 63
2024
Q1 		$988K Sell
6,258
-1,842
-23% -$252K 0.04% 91
2023
Q4 		$1.1M Sell
8,100
-8,026
-50% -$979K 0.07% 72
2023
Q3 		$1.97M Sell
16,126
-67,852
-81% -$8.63M 0.13% 63
2023
Q2 		$2.16M Buy
83,978
+66,605
+383% +$8.65M 0.1% 72
2023
Q1 		$2.21M Buy
+17,373
New +$2.27M 0.13% 62
2022
Q2 		$2.16M Buy
+83,978
New +$9.97M 0.1% 72

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return

Quintet Private Bank (Europe)'s IBB Position: Q3 2026 in Review

Quintet Private Bank (Europe) reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q3 2026, selling an estimated $20.1K and leaving 500 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #129.

Quintet Private Bank (Europe) first reported a position in IBB in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.21M in Q1 2023. 35 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Quintet Private Bank (Europe) held 500 shares of iShares Biotechnology ETF worth $105K as of Q3 2026.
  • Quintet Private Bank (Europe) sold 100 iShares Biotechnology ETF shares in Q3 2026, an estimated $20.1K.
  • iShares Biotechnology ETF made up ﹤0.01% of Quintet Private Bank (Europe)'s portfolio in Q3 2026, its #129 holding.
  • Quintet Private Bank (Europe) first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 16 quarters since.
  • Quintet Private Bank (Europe)'s iShares Biotechnology ETF position peaked at $2.21M in Q1 2023.
  • 35 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2026, filed 8 Oct 2026.